PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 6
Abstract
Background. The protein encoded by PARK2 gene is a component of the ubiquitin-proteasome system that mediates targeting of proteins for the degradation pathway. Genetic variations at PARK2 gene were linked to various diseases including leprosy, typhoid and cancer. The present study investigated the association of single nucleotide polymorphisms (SNPs) in the PARK2 gene with the development of hepatitis C virus (HCV) infection and its progression to severe liver diseases. Material and methods. A total of 800 subjects, including 400 normal healthy subjects and 400 HCV-infected patients, were analyzed in this study. The patients were classified as chronic HCV patients (group I), patients with cirrhosis (group II) and patients with hepatocellular carcinoma (HCC) in the context of cirrhosis (group III). DNA was extracted and was genotyped for the SNPs rs10945859, rs2803085, rs2276201 and rs1931223. Results. Among these SNPs, CT genotype of rs10945859 was found to have a significant association towards the clinical progression of chronic HCV infection to cirrhosis alone (OR = 1.850; 95% C. I. 1.115-3.069; p = 0.016) or cirrhosis and HCC (OR = 1.768; 95% C. I. 1.090-2.867; p value = 0.020). Conclusion. SNP rs10945859 in the PARK2 gene could prove useful in predicting the clinical outcome in HCV-infected patients.
Authors and Affiliations
Mashael Al-Anazi, Ahmed Al-Qahtani, Fahad Al-Zoghaibi, Ayman Abdo, Faisal Sanai, Waleed Al-Hamoudi, Khalid Alswat, Hamad Al-Ashgar, Mohammed Khan, Ali Albenmousa, Hanif Khalak, Mohammed Al-Ahdal
Keywords
Related Articles
- EP ID EP207220
- DOI -
- Views 104
- Downloads 0
Report of the Baveno VI Consensus Workshop
Prevalence of minimal hepatic encephalopathy in cirrhotic patients
Background. Minimal hepatic encephalopathy (MHE) has implications for health-related quality of life as well as for survival of cirrhotic patients, but a standardized diagnostic test is not available. Objective. To deter...
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Background and aims. A subclassification system for intermediate hepatocellular carcinom...
Undifferentiated embryonal sarcoma of liver in an adult masquerading as complicated hydatid cyst
Benign or malignant hepatic lesions may rarely mimic inflammatory lesions on imaging. We describe a case of young adult male presenting with pain abdomen and fever of short duration. Imaging revealed large complex multis...
Is exercise an effective treatment for NASH? Knowns and unknowns
Non-alcoholic steatohepatitis has emerged as one of the most common causes of chronic liver disease in many regions of the world. Exercise and dietary changes constitute cornerstones of overall therapy aimed at achieving...